Cola-colored urine Flashcards

1
Q

Case
CC: cola-colored urine
CAA 9/M , sees you for the first time with the chief complaint of
coke-colored urine
HPI: On day of consult, presented with gross hematuria, periorbital
edema, and scanty urine.
ROS:
(+)fever 37.9
(-)rashes
(-)easy bruisability
(-) epistaxis
(-)gum bleeding
(-) melena/hematochezia
(+)malaise
(+)headache
PMHx: no known history of trauma
No known history of intake of any substance or drug
History of cough 3 weeks ago, diagnosed to have URTI,
was treated with intake of co-amoxiclav

FMHx: no known relatives with bleeding disorders, or kidney
problems
PE: BP 130/90 HR 100 RR 23 Temp 37.7c
ambulatory, Weight for age below -1 , Length for age below -1
anicteric sclerae, pink palpebral conjunctiva, no
cervicolymphadenopathies
adynamic precordium, regular rhythm, no murmur
soft abdomen, normoactive bowel sounds, (+) CVA tenderness,
right
Pink nailbeds, (+) bipedal edema
SMR 1 (Pubic hair, penis, testes)

Laboratory
CBC:
Hgb 10.0 (LOW) 12.0- 15.0 g/dL
Hct 35 (LOW) 36 – 48%
RBC 5 3.5 – 5.5 ml/UL
MCV 65 (LOW) 80-100 FL
MCH 18 (LOW) 25-35 PG
RDW 12 11 – 16 FL
WBC 9.0 4.5 -11.0 K/UL
Segmenters 55 40-74
Lymphocytes 45 14-46
Monocytes 0 4-13
Platelet Count 350 150 – 450 K/UL

PBS: normochromic, normocytic

Urinalysis:
Color amber
Turbidity Sl. Hazy
Sp. Gravity 1.010
pH 6.0
Glucose Neg
Ketones Neg
Protein ++
Bilirubin neg
Urobilinogen neg
Casts RBC casts, hyaline casts
RBC Too numerous to count
WBC 14
Epi cells 2

Other lab exams done:
ASO titer : 300units/mL (normal=200units/mL)
Anti-DNAse B: 180 (normal= 170 units/mL)
C3: 60 (normal= 88-252 mg/dL)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

I. Primary Working Impression:

A

Acute glomerulonephritis (post-streptococcal type)/ PSGN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the basis of your diagnosis?

A

On the basis of:
History
1. Acute onset of nephritic syndrome (gross hematuria,
edema, hypertension, oliguria).
2. Symptoms occurred 1-2 weeks after an antecedent
URTI.
3. This disease is not familial.
4. Common in children 5-12
PE
1. Hypertensive (130/90)
2. Edema (periorbital and bipedal)
3. CVA tenderness/flank pain
Labs
1. Urinalysis
a. Hematuria is grossly appreciated (amber in
color, RBC is TNTC)
b. Sp. Gravity shows diluted urine
(hypovolemia)
c. Proteinuria (+2: is always present, but rarely
exceeds +3)
d. PSGN frequently presents with RBC casts,
and WBC
e. Sample is a clean catch sample (epi cells are
within normal range)
2. Mild, normochromic anemia
3. Elevated ASO titers
4. Elevated antiDNAse B
5. Depressed C3
6. Renal exams (LM: diffuse proliferation; IF: granular IgG,
C3; EM: subepithelial humps)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are your differentials?

A

—–1.IgA nephropathy—–
Rule in:
*Presentation of nephritic
syndrome
*Proteinuria is not markedly
increased
*Presence of hypertension
(30-50% in IgA nephropathy)

Rule out:
*Usual age 10-35 (index
patient is 9)
*IgA nephropathy rarely
presents with oliguria
*IgA nephropathy follows viral
syndromes; our patient had
bacterial URTI
*Serum IgA should be elevated

IgA Nephropathy vs PSGN

Light microscopy:
IgA Nephropathy –> Focal
proliferation
PSGN –> Diffuse

Immunoflorescence:
IgA Nephropathy –> Diffuse mesangial IgA
PSGN –> Granular IgG

Electron microscopy:
IgA –>Mesangial deposits
PSGN –>Subepithelial
humps

—–2.Goodpasture Syndrome—–
Rule in:
presents with nephritic syndrome
Proteinuria is not markedly increased

Rule out:
Usual age is 15-30
flank pain is rare
Hypertension is rare in
goodpasture
Anemia is IDA in goodpasture
Pulmonary hemorrhage is
seen
There should be note of anti-
GBM antibody

—–3. SLE Nephritis—–
Rule in:
Nephritis
with an antecedent URTI 1-3 weeks prior

Rule out: systemic features (rashes) of HSP are not present

—-4. Trauma—–
rule in: hematuria

Rule out: Trauma-related hematuria
does not present with
hypertension or
proteinuria/edema
There is no known history of
trauma

—–5. Urinary lithiasis—–
Rule in: hematuria
Rule out: Flank pain is usually very
prominent (renal colic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the diagnostics?

A

Management
Diagnostics:
Urinalysis
CBC
PBS
ASO titer
Anti-DNAse B
C3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment?

A

Mostly supportive
1. Fluid restriction
2. Diuretics (Furosemide 2mkdose q6-q12)
3. Antihypertensives (calcium channel blocker:
Nifedipine 0.5mkdose q4-6)
4. Sodium intake restriction
Use of penicillin antibiotics (10days) is recommended to limit
spread of the nephritogenic organisms. This, however, does not
affect natural course of the existing infection.
Prognosis
95% recovery
Hypertension and proteinuria resolves by 4-6 wks after onset
Hematuria may persist up to 1-2 yrs
C3 levels should normalize after 6-8 weeks
Recurrences are extremely rare
Acute complications of this disease result from hypertension and
acute renal dysfunction. Hypertension is seen in 60% of patients
and may be associated with hypertensive encephalopathy in 10%
of cases. Other potential complications include heart failure,
hyperkalemia, hyperphosphatemia, hypocalcemia, acidosis,
seizures, and uremia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the manifestations of Nephritic syndrome?

A

CH 511: ACUTE GLOMERULONEPHRITIS (AGN)
CM (Nephritic syndrome):
1. Tea/cola-colored urine
2. Facial or body edema (pleural effusion, pulmonary
edema, HF)
3. Hypertension
4. Oliguria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is POST STREPTOCOCCAL GLOMERULONEPHRITIS (PSGN)?

A

POST STREPTOCOCCAL GLOMERULONEPHRITIS (PSGN)
Etiology
- Nephritogenic strain of GABHS
- Disease of children, 5-12 yo (peak 6-7yo), uncommon
<3yo
- Molecular mimicry: streptococcal Ag elicit circulating
Ab which react with glomerular Ag&raquo_space; complement
activation&raquo_space; immunologic renal injury
- Exemplifies immune complex mediated reaction
o Involves activation of classic and alternative
complement pathways
o Localized in the glomeruli due to negatively
charged capillary wall, mesangial trapping,
hydrodynamic forces
Patho

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the clinical manifestations of PSGN?

A

CM
1. Latency period – Hx of infection (1-2 wks: pharyngitis
or 3-6 wks: streptococcal pyoderma)
2. Acute onset of nephritic syndrome (gross hematuria,
periorbital edema, hypertension, renal insufficiency)
PLUS:
a. 4 phases of APSGN “LOrd OF Da Rings”:
each phase 7-21d
i. Latent phase
ii. Oliguric phase
iii. Diuretic phase
iv. Resolution phase/ period of
convalescence
b. elevated ASO
c. hypocomplementenemia (N c1 and c2, low
c3 and other panels)
3. nonspecific sx – malaise, lethargy, abdominal pain, or
flank pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the diagnostics for PSGN?

A

Dx
1. UA – hematuria, dysmorphic RBC, RBC casts, WBC,
proteinuria, PMN leukocytes
2. Dec C3 - >90% decrease in acute phase, returns to N by
6-8wks after onset
3. BUN, crea – renal insufficiency, assess renal fxn
4. CBC – mild normocytic, normochromic anemia:
dilutional anemia secondary to fluid overload from
oliguria
5. Documentation of streptococcal infection
a. ASO titer – throat infection
b. Anti-deoxyribonuclease B (anti DNAse B) –
pyoderma: single best Ab titer to document
cutaneous strep infection
c. Rising Ab titers to streptococcus Ag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the findings in light microscopy, IF and EM of PSGN?

A

Light microscopy:
Enlarged,
bloodless,
glomeruli, diffuse
mesangial cell
proliferation,
increased
mesangial matrix

IF:
“lumpy-bumpy” granular deposits
of Ig and complement (C3) on GBM and in the mesangium

EM:
Electron dense deposits “subepithelial humps” on the
epithelial side of the GBM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of PSGN

A

Mgt
1. Abx – early systemic abx do not eliminate the risk of GN, to ensure eradication of pathogen
- Penicillin G 1.2 M U/dose x 10d to limit the spread of nephritogenic strains
- Alt: Erythromycin 50mkd po q12 x 10d

  1. Fluid limitation – mainstay of tx: 400ml/BSA + UO in 24h
  2. Strictly monitor I&O, weigh daily. Readjust fluid limit daily
  3. Sodium restriction - <2g Na/d
  4. Diuresis (Furosemide 1-2 mkdose q6-12h IV)
    - Titrate daily based on clinical status
  5. Antihypertensives – short-acting Ca channel blockers
    for acute BP control then diuretics once BP controlled
    - For short-acting ACEI, WOF hyperK
  6. monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis of PSGN

A

Prognosis
Time course of resolution:
The acute phase (incl C3) generally resolves within 6-8 wks
Proteinuria and HTN normalize by 4-6 wks after onset
Persistent microscopic hematuria can persist for 1-2 yrs after
onset

Oliguria, azotemia –> gross hematuria –> HTN –> C3 –> persistent proteinuria –> microscopic hematuria –> intermittent or orthostatic proteinuria

Complications:
1. Hypertensive encephalopathy – MC cause of death
- BOV, severe headache, altered mental status, new seizure
- Posterior reversible encephalopathy syndrome (PRES)
- Dx: brain MRI – parietooccipital area
2. HF – due to HTN or hypervolemia
More favorable outcome in children. Complete recovery in >95%
0.5-2% may progress to RPGN, reaching ESRD within weeks to
mos 2nd attacks unusual. Hx of recurrent nephritis should prompt
investigation for chronic renal ds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the other name of IgA Nephropathy?

A

BERGER DISEASE

IG A NEPHROPATHY/ BERGER DISEASE
- MC form of primary GN in the world
- MC chronic glomerular ds in children
- Ab-mediated glomerular ds
- Immune deposits (IgA) localize to the mesangium
- Differentiated from APSGN by: lack of latent phase, N
c3
- Synpharyngitic: gross hematuria often occurs after 1-
2d of URTI or GIT infection
- M>F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pathophysiology of IgA nephropathy

A

Patho
- Galactose-deficient IgA1 act as autoAg that trigger
production of Ab and formation of immune complexes
deposited in the renal mesangium –> glomerular injury
by proinflammatory cytokine release, chemokine, and
macrophage migration to the kidney –> glomerular
deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical manifestations?

A

CM
1. Recurrent Gross/microscopic hematuria and/or proteinuria

  1. May present with nephrotic or nephritic syndrome, or combined nephritic-nephrotic syndrome
  2. Onset within 1-2 days of viral URTI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the 3 syndromes?

A

3 syndromes:
1. Recurrent macroscopic (synpharyngitic) hematuria

  1. Asymptomatic microscopic hematuria and variable
    proteinuria
  2. HSP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the diagnostics for IgA Nephropathy?

A

Dx
1. UA – hematuria
2. Proteinuria <1000 mg/d
3. Normal C3
4. Serum IgA – no diagnostic value (inc in only 15%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the findings in light microscopy, IF and EM of IgA Nephropathy?

A

IgA Nephropathy/Berger Disease
Light microscopy:
Focal and segmental
mesangial proliferation and
increased mesangial matrix
in the glomerulus

IF:
Diffuse IgA deposits in the
mesangium with C3 complement

EM:
Mesangial deposits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

management of IgA nephropathy

A

Mgt
1. ACEI, ARBs - BP control and Mgt of proteinuria
2. fish oil (omega-3-FAs) – decrease rate of renal
progression
3. CS – if ACEI and ARBs are ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Prognosis of IgA nephropathy

A

Prognosis
- 40% renal function progressively worsens
- 30% benign course with chronic microscopic
hematuria, N crea, proteinuria <1g/d
- 20% ESRD after 20 yrs of clinically apparent ds
- HTN common, malignant HTN in 5%
- Poor prognosis: persistent HTN, renal dysfunction,
heavy/prolonged proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is Henoch-Schonlein Purpura Nephritis?

A

HENOCH-SCHONLEIN PURPURA (HSP) NEPHRITIS
- Idiopathic systemic immune complex-mediated
vasculitis with IgA deposits in the small BV walls
- Any mucosal infection or food Ag may trigger the inc
production of pathogenic IgA
- Etiology unknown
- More freq in children 2-8 yo; M>F
Patho
- IgA deposition in glomeruli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the clinical manifestations of HSP Nephritis?

A

CM
1. Preceded by URTI (1-3 wks)
2. LG fever, fatigue
3. Tetrad of HSP:
a. Palpable purpuric rashes on dependent
parts of the body – hallmark
b. Arthritis or arthralgia
c. Abdominal pain
d. Renal ds (25-50%)
4. Hematuria + proteinuria – within first 3 mos of ds
a. Majority have isolated hematuria
b. Resolve spontaneously

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is HSP Nephritis diagnosed?

A

Dx
1. UA – asymptomatic microscopic hematuria to severe
progressive GN
2. CBC – anemia, mod thrombocytosis and leukocytosis
3. Elevated ESR
4. Elevated IgA and IgM
5. ANA, ANCA, RF (-)
6. Anticardiolipin and antiphospholipid ab (+)
7. N C3 – distinguishes HSP from APSGN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Findings of HSP Nephritis in light microscopy, IF and EM
Light microscopy: Leukocytoclastic vasculitis/angiitis with IgA C3, and fibrin deposition IF: Deposition of polymeric IgA in the glomeruli EM: Mesangial deposits
26
What is the management of HSP nephritis?
1. UA - Done weekly during active ds then once monthly for 6 mos (if all N, GN unlikely) 2. Mild: resolves spontaneously 3. Moderate to severe ds: a. CS (prednisone 1mkd x 3 mos) b. ACEI c. Followed by azathioprine or mycophenolate if persistent 4. Refer to nephro – if with proteinuria, renal insufficiency, HTN 5. Adequate hydration, bland diet 6. Pain control with Pct
27
Prognosis of HSP nephritis
Prognosis 2-5% risk of CKD Older children and adolescents have more severe ds Majority do not have severe renal ds/ serious sequelae
28
What is HUS?
HEMOLYTIC UREMIC SYNDROME (HUS) - One of the MC cause of ARF in young children - Usually preschool and school-aged children, MC <4yo Etiology - MC form due to Shiga toxin-producing E.coli 0157:H7 (STEC) - SLE, HELLP syndrome, genetics, drugs (calcineurin inhibitors, cytotoxic agents, clopidogrel, ticlopidine, quinine) Patho - Toxin initiates endothelial cell injury which leads to microvascular injury - Microangiopathic anemia due to mechanical damage to RBCs as they pass through the altered vasculature - Thrombocytopenia due to intra-renal platelet adhesion or damage
29
What is the triad of HSP nephritis?
Triad a. Microangiopathic hemolytic anemia b. Thrombocytopenia c. Renal insufficiency
30
Other clinical manifestations of HUS
1. Triad a. Microangiopathic hemolytic anemia b. Thrombocytopenia c. Renal insufficiency 2. Hx of bloody AGE within the preceding 3 weeks 3. Sudden onset of pallor, irritability, weakness, lethargy, oliguria 4. Usually 5-10d after initial illness 5. Dehydration, petechiae, hepatosplenomegaly, marked irritability 6. CV: HTN, pericarditis, myocardial dysfunction, arrythmia 7. E’ abN – hyperK, hypoNa 8. CNS – encephalopathy, sz 9. GI – inflammatory colitis, ischemic enteritis, bowel perforation, intussusception, bleeding
31
Laboratory criteria of HUS
The following re both present at some time during the illness: 1. Anemia (acute onset) with microangiopathic changes (schistocytes, burr cells, helmet cells) on PBS 2. Acute renal injury: hematuria, proteinuria, elevated creatinine levels (>1.5 mg/dL in >13 years old or ≥50% increase over baseline
32
Classification of HUS
-----PROBABLE----- meets lab criteria but with no clear history of diarrhea in the preceedig 3 weeks or onset within 3 weeks of diarrhea, and meets the lab criteria except that microangiopathic changes are not confirmed -----CONFIRMED----- meets the laboratory criteria AND began within 3 weeks of diarrhea
33
Other diagnostics
1. PBS – microangiopathic hemolytic anemia, Helmet cells, burr cells, fragmented RBCs 2. CBC – anemia, thrombocytopenia (20K-100K), leukocytosis 3. Inc reticulocyte count 4. (-)Coomb’s test 5. Elevated BUN and crea, ARF 6. UA – hematuria, proteinuria 7. N PT and PTT 8. Stool C/S – negative usually 9. Renal biopsy – glomerular thickening of capillary walls, narrowing of capillary lumen, plt-fibrin thrombi in glomerular capillaries, thrombi in afferent arterioles with fibrinoid necrosis
34
Management of HUS
Mgt 1. Supportive tx and hydration 2. PRBC transfusion 3. Correction of e’ abN 4. Control of HTN 5. Dialysis 6. Plt transfusion – generally not done 7. No Abx – may precipitate toxin release
35
What is RPGN?
RAPIDLY PROGRESSIVE (CRESCENTIC) GLOMERULONEPHRITIS (RPGN) CM 1. Acute nephritis with proteinuria or nephrotic syndrome 2. Rapid loss of renal function – deterioration within 3 weeks to 3 mos 3. Renal failure/ insufficiency 4. Primary or secondary to other conditions (IgA nephropathy, HSP nephritis, PSGN, SLE) 5. Most often idiopathic
36
Diagnostics for RPGN
Dx 1. ID cause of RPGN 2. Crescent = ominous sign, poor prognosis Light microscopy: Crescents in 50% or more in the glomeruli IF: No immune deposits. ID underlying cause EM: No deposits 3. Renal biopsy – indications a. ARF b. Nephrotic syndrome that is persistently hypertensive c. C3 will not normalize in 6-8 weeks in nephritic syndrome d. High suspicion that it is secondary GN that is not post-infectious or MCD e. Steroid-resistant, relapsing requiring medications other than steroids
37
Management of RPGN
Mgt 1. High-dose CS 2. Cyclophosphamide 3. ESRD in most pxs 4. Guarded prognosis High-dose CS 2. Cyclophosphamide 3. ESRD in most pxs 4. Guarded prognosis 5. Always refer if secondary GN because multispecialty mgt needed
38
When do we suspect Nephrotic Syndrome?
CH 527: NEPHROTIC SYNDROME (NS) - Suspect when there is nephrotic range proteinuria (>3.5 g/d or UPCR >2) PLUS the clinical triad of nephrotic syndrome: o Hypoalbuminemia (<2.5g/dl) o Edema o Hyperlipidemia (cholesterol >200mg/dl) - “EPAL”: Edema, Proteinuria, Albuminemia (hypo), Lipidemia (hyper)
39
Approach to edema
Approach to edema: Where did the edema 1st manifest? Face going down - renal bipedal edema going up - cardiac central - liver others – nutritional
40
Etiopathogenesis of Nephrotic Syndrome
Etiopatho - M>F - MCD NS: MC in children (90%) - Non-MCD (10%): FSGS, MPGN, C3 GN, MN - Most respond to steroids - Among those nonresponsive to CS, 80% would be FSGS - Ongoing inflammation affects the physical barrier à wider podocyte spaces/ effacement and abnormal charge of barrier (- to +) à protein leakiness across glomerular capillary wall into urinary space
41
Clinical manifestations of Nephrotic syndrome?
CM Hallmarks of NS: 1. Heavy proteinuria (40mg/m2/h) – due to inc permeability of the glomerular capillary wall 2. Hypoalbuminemia (<2.5g/dl) – due to urinary protein loss 3. Edema - Underfill hypothesis: proteinuria leads to a decrease in plasm protein and low intravascular oncotic P, resulting in leakage of plasma water into interstitium, leading to edema - Overfill hypothesis: NS is associated with urinary sodium retention leading to volume expansion and leakage of excess fluid into the interstitium - Reduced intravascular volume result to increased vasopressin and Atrial natriuretic factor and aldosterone, which result to inc Na and water retention by the tubules 4. Hyperlipidemia – low albumin stimulates generalized hepatic protein synthesis - Increased urinary loss of lipoprotein lipase causes decreased lipid catabolism this elevating serum lipid levels 5. Others: a. Anorexia, irritability, abdominal pain b. HTN, gross hematuria (uncommon)
42
Types of Nephrotic Syndrome
Types 10% have secondary NS 90% have idiopathic NS: 1. Minimal change disease (85%): 95% respond to CS 2. FSGS (10%): only 20% respond to CS 3. Mesangial proliferation (5%): 50% respond to CS
43
Overview of the types of Nephrotic Syndrome
p. 204
44
General work-up for PROTEINURIA
-----1. Urine Disptick Test----- Routine screening in selected population Interpretation: Normal should be negative or trace if specific gravity (SG ≥1.020; nephrotic range usually +3 or +4; dipstick interpretation: Trace 10-29 mg/dl 1+: 3-100mg/dl 2+: 100-300mg/dl 3+: 300-1000mg/dl 4+: >1000mg/dl Normal SG: 1.015-1.025 Remarks: False-positive: Alkaline urine PH>7.0 or very concentrated urine (SG>1.025); presence of blood, pyuria, prolonged dipstick immersion False negative: low urine pH (<4.5);; dilute urine, if albumin is not the urinary protein -----2. 24-hr Urine Protein and Creatinine Excretion----- Quantitation of proteinuria Normal: <100mg/m2/24h or <150mg/24hr Nephrotic range: 3.5g/24hr or >40 mg/m2/hr Remarks: more accurate -----3. Spot urine for Protein/creatinine Ratio (UPCR)----- semiquantitative assessment of proteinuria Normal: <0.2mg protein/mg creatinine in >2yrs old <0.5 mg protein/mg creatinine in 6-24 mos nephrotic range: >2mg protein/mg creatinine Remarks: easier collection; use first morning void, less accurate than 24hr urine collection; not readily available -----4. microalbuminuria----- Assess risk of progressive glomerulopathy Normal: <30mg of urine albumin per gram of creatinine on first morning void
45
General work-up for proteinuria
1. UA – 3+ to 4+ proteinuria - Significant proteinuria = trace with sp gr <0.010 or >1+ with sp gr >0.015 2. Urine protein - >40 mg/m2/h - 24 hr urine collection: 4-40= abnormal 3. Urine protein-creatinine ratio (UPCR) >2 - NV = <0.5 in children <2yo <0.2 in >2yo - Spot urine crea total protein: >2 = nephrotic range 0.2-2 = abnormal protein excretion <0.2 = normal 4. N serum crea, BUN 5. Serum albumin <2.5 g/dl - NV = 2.5-3.5 6. Elevated serum cholesterol & TG 7. N C3 and C4 8. Renal biopsy – indications: a. Gross hematuria b. HTN c. Renal insufficiency d. Hypocomplementenemia e. Age <1 yo or >12 yo
46
Management of Nephrotic syndrome
Mgt 1. CS – if onset 1-8yo: likely steroid-responsive MCD (CS may be initiated w/o biopsy) - Prednisone 60mg/m2/d or 2mkd (max 60mg daily) for 4-6 weeks - IF (-) proteinuria: Taper prednisone after 4 weeks to alternate day tx (starting at 40mg/m2/d or 1.5mkd) for 4 weeks then taper gradually over 4 weeks - 12 weeks total duration
47
response
remission attained during first 4 weeks of steroid therapye
48
mission
UPCR <0.2 or dipstick <1 for 3 consecutive days
49
Relapse
UPCR >2 or dipstick ≥3+ for 3 consecutive daysS
50
Steroid dependent
two consecutive relapses during corticosteroid therapy or within 14 days of ceasing therapy
51
Steroid resistant
Failure to achieve complete remission after 8 weeks of steroid therapy; requires renal biopsy and referral to specialist
52
Frequent relapser
>2 relapses within 6 mos of initial response or >4 relapses within 12 mos
53
Other management
2. Admission/OPD - OPD: 1st episode w/ mild-mod edema - Admit: severe sx’c edema (effusion, ascites) - r/o TB prior to CS tx 3. fluid balance – fluid restriction and low sodium diet 4. diuretics – furosemide 1mkdose IV 5. IV 25% human albumin 0.5 g/kg for 2-4hrs with postinfusion of furosemide daily - For massive/sx’c pleural effusions (dyspnea), ascites, scrotal/labial edema (difficulty ambulating), oliguria - Temporary relief 6. Monitor volume status, serum e’s, renal fxn 7. Vaccination – pneumococcal vaccine when in remission and off daily CS - varicella vaccine when prednisone <1mkd daily or 2mg/kg on alternate days - Influenza vaccine 8. Treat concurrent infection with abx – 3rd gen ceph 9. Steroid-sparing – Tacrolimus, cyclophosphamide
54
What are the complications of nephrotic syndrome?
Complications 1. Infection – major complication (spontaneous bacterial peritonitis (SBP), bacteremia) - S.pneumonia (MC in children) and E.coli - Peritoneal leukocyte count >250 cells/uL highly suggestive of SBP 2. Hypovolemia 3. Thrombosis – do preventive ambulation 4. Malnutrition 5. Acute renal failure
55
What is the prognosis?
Prognosis - If steroid-resistant: FSGS is usual form with poorer prognosis - In remission: pxs are considered N and may have unrestricted diet and activity
56
What is urolithiasis?
CH 547: UROLITHIASIS - 90% calcium - 60% Ca oxalate - Cystine, UA, indinavir, melamine - RF: low urine volume, low urine pH (acidic), Ca, Na, oxalate, urate - Ca stones – ketogenic diet, CS, VitD - Struvite stone – UTI, FB, urine stasis - When urine contains more crystal-forming substances (Ca, oxalate, uric acid) --> kidney stone formation in renal parenchyma or renal collecting system --> pass to ureter/ bladder --> calculi may lodge in the ureter causing hydroureter/hydronephrosis
57
What are the clinical manifestations of urolithiasis?
CM 1. Severe flank pain (renal colic), intermittent at ureteropelvic junction (narrowest segment) 2. Dysuria, urgency, frequency (distal ureter) 3. Asx’c – if at bladder
58
What are the diagnostics of urolithiasis?
Dx 1. PFA – radiopaque stones (ca oxalate/PO4, struvite), radiolucent (urica acid, cystine) 2. Unenhanced spinal CT scan of abdomen, pelvis – most accurate. Opaque stones 3. Renal UTZ – echogenic foci, acoustic shadowing , twinkle artifact on color doppler
59
Management of urolithiasis
Mgt 1. Alpha-adrenergic bladder – Tamsolusin, Terazosin, Doxazosin: decrease P and peristaltic contractions 2. Ureteral stent 3. Lithotripsy (ESWL) – for large proximal calculi - Indication for surgical mgt: a. Stones >5mm b. Extended duration of sx c. Location of the stone with proximal calculi less likely to spontaneously pass d. Infection/sepsis e. Pilot/truck driver due to risk of renal calculi during work f. Solitary kidney g. Failed conservative mgt 4. Diet – dec Na, oxalate, inc hydration 5. Alkalinization of urine
60
What is renal TB?
CH ?: RENAL TB Refer to TB (p.36) CM 1. Dysuria, hematuria, flank pain 2. Albuminuria, proteinuria, sterile pyuria
61
What is renal tubular acidosis (RTA)?
CH 529: RENAL TUBULAR ACIDOSIS (RTA) - Characterized by normal anion gap hyperchloremic metabolic acidosis in the setting of normal or nearnormal GFR
62
What is Proximal (TYPE II) RTA?
*Inherited and persistent from birth or occur transiently during infancy *Usually occurs as a component of global proximal tubular dysfunction (Fanconi syndrome: proteinuria, glycosuria, phosphaturia, aminoaciduria and proximal RTA) CM: growth failure in the 1st year of life, polyuria, hyponatremic dehydration, anorexia, vomiting, constipation, hypotonia, hypokalemia
63
What is DISTAL (TYPE I) RTA?
*sporadic or inherited *can occur as a complication of inherited or acquired diseases of the distal tubules *results from impaired H+ ion excretion so urine pH cannot be reduced to <5.5 CM: growth failure, hypokalemia, nephrocalcinosis, and hypercalciuria Absent phosphate and bicarbonate wasting
64
What is HYPERKALEMIC (TYPE IV) RTA?
*due to impaired aldosterone production (hypoaldosteronism) or impared renal responsiveness to aldosterone (pseudohypoaldosteronism) *Aldosterone has a direct effect on hydrogen secretion and stimulates K+ secretion in the collecting tubules *lack of aldosterone results in acidosis and hyperkalemia CM: growth failure, hyperkalemia polyuria and dehydration from salt wasting are common urine may be alkaline or acidic high urinary sodium levels with inappropriately low urinary K+
65
What is COMBINED PROXIMAL AND DISTAL (TYPE III) RTA?
*very rare, autosomal recessive *due to inherited carbonic anhydrase 2 deficiency *features of both proximal and distal RTA CM: associated with osteopetrosis or marble stone disease, cerebral calcification and mental retardation CM: growth failure, bone fractures, facial dysmorphism, conductive hearing loss and blindness
66
Diagnosis of RTA
-----PROXIMAL RTA----- urine pH with acidosis: <5.5 urine net charge: negative Fanconi lesions: present Fractional bicarbonate excretion: >10-15% during alkali therapy responsive to therapy: least responsive associated disease: Fanconi syndrome -----CLASSIC DISTAL RTA----- urine pH with acidosis: >5.5 urine net charge: positive Fanconi lesions: absent Fractional bicarbonate excretion: 2-5% responsive to therapy: responsive associated disease: Nephrocalcinosis -----GENERALIZED DISTAL DYSFUNCTION----- urine pH with acidosis: <5.5 to >5.5 urine net charge: positive Fanconi lesions: absent Fractional bicarbonate excretion: 5-10% responsive to therapy: less responsive associated disease: Renal insufficiency 1. E’s, ABG, BUN, Crea, UA
67
What is the mainstay of management for all types of RTA?
Mgt 1. Bicarbonate replacement – mainstay of tx in all forms of RTA a. Proximal RTA – bicarbonate up to 20 mEq/k/d (sodium bicarbonate or sodium citrate solution) b. Distal RTA – base requirement is generally 2-4 mEq/k/d and required monitoring for the devt of hypercalciuria. i. Thiazides – for sx’c hypercalciuria, nephrocalcinosis, or nephrolithiasis to decrease urine Ca excretion 2. Phosphate supplementation – for Fanconi syndrome 3. Sodium-potassium exchange resin – for type IV RTA as chronic tx for hyperkalemia Prognosis - Depends on nature of existing underlying disorder - Isolated RTA generally show improvement in growth if bicarbonate levels are within N range
68
What is Acute Kidney Injury and give clinical manifestations
CH 535: ACUTE AND CHRONIC RENAL FAILURE ACUTE KIDNEY INJURY - Abrupt loss of kidney function, which leads to rapid decline in the GFR, accumulation of waste products, and dysregulation of extracellular volume and electrolyte homeostasis CM 1. Prerenal AKI – tachycardia, dry mucus membranes, poor perfusion 2. Intrinsic AKI – HTN, peripheral edema, rales, cardiac gallop suggesting volume overload 3. Rash, arthritis - rheuma
69
Diagnostics for AKI?
1. CBC – anemia (dilutional/hemolytic), leukopenia, thrombocytopenia 2. E’ – hypoNa, hyperK, hyperP, hypoCa 3. ABG – metabolic acidosis 4. Elev BUN, Crea 5. Elev uric acid 6. UA – hematuria, proteinuria, (+)RBC casts, granular casts = GN/ATN vs. WBC/WBC casts = tubuloint. Ds
70
What is the Pediatric RIFLE criteria?
-----RISK----- Crea: increase >1.5x eGFR: decreased by 25% UO: <0.5ml/kg/hr for ≥8 hours -----INJURY----- Crea: Increase ≥2x eGFR: decreased by ≥50% UO: <0.5ml/kg/hr for ≥16 hours ------FAILURE----- Crea: increase ≥3x or >4 mg/dl with an acute rise of 0.5 mg/dl eGFR: decreased by ≥75% or <35ml/min/1.73m2 UO: <0.3ml/kg/hr for ≥24 hours or anuria for ≥12 hours -----LOSS----- persistent failure > 4weeks -----End-stage----- persistent failure > 3 months
71
Common causes of AKI
-----PRERENAL----- decreased effective circulating arterial volume leading to inadequate perfusion and decreased GFR dehydration, AGE, burns, sepsis, hemorrhage, capillary leak hypoalbuminemia cardiac failure anaphylaxis cirrhosis abdominal compartment syndrome -----INTRINSIC RENAL------ renal parenchymal damage with sustained hypoperfusion and ischemia Glomerulonephritis HUS ATN Renal vein thrombosis Acute interstitial nephritis Rhabdomyolysis tumor infiltration drugs and toxins Tumor lysis syndrome vasculitis cortical necrosis -----POSTRENAL----- obstruction of the urinary tract posterior urethral valves urolithiasis tumors ureteropelvic and ureterovesicular junction obstruction urethral strictures hemorrhagic cystitis neurogenic bladder anticholinergic drugs
72
Urinalysis results
results: Pre-renal AKI Intrinsic AKI Sp gravity >1.020 <1.010 UOsm >500 mOsm/kg <350 Una <20 mEq/L >40 Fractional excretion of Na <1% (<2.5% in NB) >2% (>10% in NB)
73
Management of AKI
Mgt 1. bladder catheter – to ensure adequate drainage of urinary tract 2. IVF - isotonic saline 20ml/kg for 30min for volume resuscitation - Prerenal AKI voids within 2hrs 3. After resuscitation, furosemide (2-4mg/kg) and mannitol (0.5 g/kg) + dopamine (2-3 ug/kg/min) to increase renal cortical blood flow 4. Correct e’ abN a. hyperK – ECG monitoring, Kayexalate b. hypoCa – Ca carbonate/acetate, low P diet c. hypoNa – hypertonic 3% NSS 5. Ranitidine – for GI bleed 6. BP control – diuretic 7. Sz control – BZD 8. Anemia - PRBC 9. Diet – restrict Na, K, and Phosphorus. 10. Dialysis
74
Indications for dialysis in AKI
Indications for Dialysis in AKI: 1. Anuria/ oliguria 2. Volume overload with HTN/ pulmonary edema refractory to diuretics 3. Persistent hyperkalemia 4. Severe metabolic acidosis unresponsive to therapy 5. Uremia (encephalopathy, pericarditis, neuropathy) 6. BUN >100-150 mg/dl (or lower if rapidly rising) 7. Ca:Phosphorus imbalance, with tetany that cannot be controlled 8. Inability to provide adequate nutrition due to severe fluid restriction
75
What is Chronic Kidney Disease? Give the criteria
CHRONIC KIDNEY DISEASE (CKD) Criteria for definition of CKD: 1. Kidney damage for >3 months - Structural or functional abnormalities of the kidney, with or without decreased GFR, manifested by >1 of the ff: a. abN composition of blood or urine b. abN imaging tests c. abN kidney biopsy 2. GFR <60 ml/min/1.73m2 for >3 months, with or without the other signs of kidney damage described above
76
Stages of CKD
STAGE 1: Kidney damage with normal or increased GFR GFR (ml/min/1.73m2): >90 STAGE 2: Kidney damage with mild decrease in GFR GFR (ml/min/1.73m2): 60-89 STAGE 3: moderate decrease in GFR GFR (ml/min/1.73m2): 20-59 STAGE 4: severe decrease in GFR GFR (ml/min/1.73m2): 5-29 STAGE 5: Kidney Failure GFR (ml/min/1.73m2): <15 or on dialysis
77
Clinical manifestations of CKD
CM 1. Edema, HTN, hematuria, proteinuria 2. FTT, polyuria, dehydration, overt renal insufficiency 3. Headache, fatigue, lethargy, anorexia, vomiting, polydipsia, polyuria, growth failure 4. Pallor, sallow appearance, short stature, edema, fluid overload
78
What are the diagnostics for CKD?
Dx 1. CBC – normochromic normocytic anemia 2. Elevated BUN, Crea 3. E’ abN – hyperK, hypo/hyperNa, acidosis, hypoCa, hyperP, elev uric acid 4. Hypoalbuminemia 5. Elevated cholesterol and TG 6. UA – hematuria, proteinuria
79
Management of CKD
Mgt 1. Monitoring - Routine serum e’s, BUN, Crea, Ca, P, albumin, ALP, CBC, echo (r/o cardiac complication) 2. Refer to nutritionist/GI 3. Vit D therapy (calcitriol) – cornerstone of tx for renal osteodystrophy - Due to secondary hyperparathyroidism (monitor PTH) - Muscle weakness, bone pain, fractures with minor trauma 4. Fluid and e’ mgt – high volume low caloric density feedings 5. Mgt of HTN – thiazide diuretics à ACEI, ARBs
80
Other differentials
UTI
81